A feasibility study of the AutoPap system location-guided screening

J S Lee1, L Kuan, S Oh

  • 1NeoPath, Inc., Redmond, Washington 98052, USA.

Acta Cytologica
|February 28, 1998
PubMed
Summary

The AutoPap System accurately identifies abnormal cervical cells, improving diagnostic accuracy and reducing workload. Location-guided screening significantly lowers false negatives for LSIL+ cases.

Related Concept Videos